You must log in to view this page.

Gain Therapeutics Inc. – Underwriting Agreements

NASDAQ: GANX
Share price (8/17/26): $2.04
Market cap (8/17/26): $89.0 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

EX-1.1

from 8-K 47 pages Underwriting Agreement Between Gain Therapeutics, Inc. and Newbridge Securities Corporation

12/34/56

EX-1.1

from 8-K 44 pages Gain Therapeutics, Inc. $50,000,000 Common Stock Equity Distribution Agreement

12/34/56

EX-1.1

from 8-K 45 pages Shares of Common Stock (Or Pre-Funded Warrants in Lieu Thereof) Gain Therapeutics, Inc. Underwriting Agreement

12/34/56

EX-1.1

from 8-K 46 pages Underwriting Agreement Between Gain Therapeutics, Inc. and Newbridge Securities Corporation

12/34/56

EX-1.2

from S-3 45 pages Gain Therapeutics, Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

12/34/56

EX-1.1

from 8-K 31 pages Gain Therapeutics, Inc. Common Stock Underwriting Agreement

12/34/56

EX-1.1

from S-1/A 31 pages Gain Therapeutics, Inc. Common Stock Underwriting Agreement

12/34/56

Gain Therapeutics Inc. – Underwriting Agreements Watch

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

Gain Therapeutics Inc. – Underwriting Agreements